SELLAS Life Sciences to present preclinical data on SLS009 at AACR 2026
SELLAS Life Sciences plans to present preclinical data on SLS009 in pancreatic ductal adenocarcinoma at the 2026 AACR Conference on Pancreatic Cancer.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.